Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin plus pneumatic compression versus pneumatic compression alone for VTE prevention after abdominoplasty
IRCT20241201063905N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Sep 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of heparin in venous thromboembolism (VTE) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Incidence of venous thromboembolism, Incidence of deep vein thrombosis at 6 hours and 3 more. Started Sep 2024; status: completed.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20241201063905N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241201063905N1.